{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:28:06Z","timestamp":1792427286802,"version":"4.5.0"},"reference-count":54,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Health (London)"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Until recently, the only medical treatment available for the hepatitis C virus (HCV) was interferon-based therapy, a notoriously long and arduous treatment with limited success. However, in December 2015, the Australian Government announced a scheme of \u2018universal access\u2019 to new, highly effective direct-acting antiviral therapies (DAAs). This article draws on in-depth interviews with community actors engaged in national and state-based drug user and viral hepatitis advocacy to trace how universal access to curative medicines affords revised notions of citizenship and social inclusion among people who inject drugs and others affected by HCV. To inform our analysis, we draw on and combine critical perspectives from the biological citizenship literature, particularly pharmaceutical citizenship, along with work on the concepts of \u2018publics and counterpublics\u2019. We ask: what kinds of emergent HCV communities or publics are being enacted through our participant accounts in response to the new DAA-era of universal access, and what forms of citizenship and inclusion (or non-citizenship and exclusion) do they postulate? Some accounts indeed enacted treatment as an individual, sometimes collective, \u2018good\u2019: a citizenship potential. However, a number of accounts enacted situated limits to a straightforward actualisation of this potential, performing a model of public health governance that prioritised viral cure whilst rendering injecting drug use and its attendant social disadvantages an absent presence. Reconceptualising HCV treatment within a counterpublic health sensibility would, by engaging with the everyday health needs and aspirations of people living with HCV in conditions of social disadvantage, create space for new social inclusions and citizenships.<\/jats:p>","DOI":"10.1177\/1363459320988887","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T12:18:10Z","timestamp":1611836290000},"page":"736-752","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limits"],"prefix":"10.1177","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7782-1235","authenticated-orcid":false,"given":"Jake","family":"Rance","sequence":"first","affiliation":[{"name":"UNSW Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rhodes","sequence":"additional","affiliation":[{"name":"UNSW Sydney, Australia"},{"name":"London School of Hygiene and Tropical Medicine, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Lancaster","sequence":"additional","affiliation":[{"name":"UNSW Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"bibr1-1363459320988887","unstructured":"Australian Government Department of Health (2015) Turnbull govt invests over $1B to cure Hep C [Media release], 20 December. Available at: https:\/\/hepatitisact.com.au\/noticeboard\/page\/4\/ (accessed 20 November 2019)."},{"key":"bibr2-1363459320988887","volume-title":"Fifth National Hepatitis C Strategy 2018\u20132022","author":"Australian Government Department of Health and Ageing","year":"2019"},{"key":"bibr3-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1057\/978-1-137-52546-8"},{"key":"bibr4-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13514"},{"key":"bibr5-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.06.007"},{"key":"bibr6-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1353\/anq.2007.0056"},{"key":"bibr7-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-anthro-091908-164420"},{"key":"bibr8-1363459320988887","unstructured":"Burnet Institute and Kirby Institute (2019) Australia\u2019s progress towards hepatitis C elimination. Annual report 2019, Burnet Institute, Melbourne."},{"key":"bibr9-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1080\/17530350.2010.494117"},{"key":"bibr10-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2008.01124.x"},{"key":"bibr11-1363459320988887","doi-asserted-by":"publisher","DOI":"10.4135\/9781849208758.n4"},{"key":"bibr12-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ197"},{"key":"bibr13-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2018.02.006"},{"key":"bibr14-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1177\/1363459314530740"},{"key":"bibr15-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1080\/13648470500291360"},{"key":"bibr16-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1177\/1363459304041070"},{"key":"bibr17-1363459320988887","volume-title":"Making Disease, Making Citizens: The Politics of Hepatitis C","author":"Fraser S","year":"2011"},{"key":"bibr18-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1080\/19460171.2016.1191365"},{"key":"bibr19-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36810"},{"key":"bibr20-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13453"},{"key":"bibr21-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.03.015"},{"key":"bibr22-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.07.015"},{"key":"bibr23-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2013.01.031"},{"key":"bibr24-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.08.004"},{"key":"bibr25-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.12.018"},{"key":"bibr26-1363459320988887","unstructured":"Kirby Institute (2017) Monitoring hepatitis C treatment uptake in Australia (Issue 6), Sydney, Australia, February 2017: The Kirby Institute, UNSW Sydney."},{"key":"bibr27-1363459320988887","unstructured":"Kirby Institute (2019) Monitoring hepatitis C treatment uptake in Australia (Issue 10), Sydney, Australia, June 2019: The Kirby Institute, UNSW Sydney."},{"key":"bibr28-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1177\/089124195024003003"},{"key":"bibr29-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1080\/13645579.2015.1123555"},{"key":"bibr30-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2017.01.031"},{"key":"bibr31-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.04.002"},{"key":"bibr32-1363459320988887","doi-asserted-by":"publisher","DOI":"10.4324\/9780203481141"},{"key":"bibr33-1363459320988887","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb01712.x"},{"key":"bibr34-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-018-0248-4"},{"key":"bibr35-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.2014.26.3.234"},{"key":"bibr36-1363459320988887","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20160008"},{"key":"bibr37-1363459320988887","doi-asserted-by":"publisher","DOI":"10.4324\/9780203927076"},{"key":"bibr38-1363459320988887","first-page":"124","volume-title":"Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems","author":"Nguyen V-K","year":"2005"},{"key":"bibr39-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1080\/09581596.2016.1140127"},{"key":"bibr40-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.12347"},{"key":"bibr41-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1080\/09581596.2010.518379"},{"key":"bibr42-1363459320988887","volume-title":"Life Exposed: Biological Citizens after Chernobyl","author":"Petryna A","year":"2002"},{"key":"bibr43-1363459320988887","doi-asserted-by":"publisher","DOI":"10.2307\/2783568"},{"key":"bibr44-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1215\/9780822390886"},{"key":"bibr45-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2011.10.003"},{"key":"bibr46-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1111\/add.12392"},{"key":"bibr47-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.12018"},{"key":"bibr48-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.06.023"},{"key":"bibr49-1363459320988887","first-page":"439","volume-title":"Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems","author":"Rose N","year":"2005"},{"key":"bibr50-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-016-0071-z"},{"key":"bibr51-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12677"},{"key":"bibr52-1363459320988887","doi-asserted-by":"publisher","DOI":"10.1215\/08992363-14-1-49"},{"key":"bibr53-1363459320988887","unstructured":"World Health Alliance (n.d.) Find the missing millions campaign. Available at: https:\/\/www.worldhepatitisalliance.org\/missing-millions\/about\/ (accessed 27 March 2020)."},{"key":"bibr54-1363459320988887","volume-title":"Global Health Sector Strategy on Viral Hepatitis 2016\u20132021: Towards Ending Viral Hepatitis","author":"World Health Organization","year":"2016"}],"container-title":["Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1363459320988887","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1363459320988887","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1363459320988887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:31:17Z","timestamp":1777447877000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1363459320988887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1177\/1363459320988887"],"URL":"https:\/\/doi.org\/10.1177\/1363459320988887","relation":{},"ISSN":["1363-4593","1461-7196"],"issn-type":[{"value":"1363-4593","type":"print"},{"value":"1461-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}